IHM
AVDL

Iguana Healthcare Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Iguana Healthcare Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-25,000
Closed -$530K – 75
2015
Q2 		$530K Buy
+25,000
New +$448K 0.17% 65

Other funds holding AVDL

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Iguana Healthcare Management's AVDL Position: Q4 2016 in Review

Iguana Healthcare Management sold out of Avadel Pharmaceuticals (AVDL) in Q4 2016, closing a stake of 400,000 shares — an estimated $4.96M sold.

Iguana Healthcare Management first reported a position in AVDL in Q2 2014 and held it in 4 quarters. The position peaked at $4.96M in Q3 2016. 76 funds tracked by Wall St. Rank hold AVDL as of Q4 2016.

  • Iguana Healthcare Management reported no remaining Avadel Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Iguana Healthcare Management sold 400,000 Avadel Pharmaceuticals shares in Q4 2016, an estimated $4.96M.
  • Iguana Healthcare Management first reported a position in Avadel Pharmaceuticals in Q2 2014 and held it in 4 quarters.
  • Iguana Healthcare Management's Avadel Pharmaceuticals position peaked at $4.96M in Q3 2016.
  • 76 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2016.

Based on Iguana Healthcare Management's 13F filing for Q4 2016, filed 14 Feb 2017.